FDA Inspection
Teva Pharmaceutical Industries Ltd.Teva Pharmaceutical Industries Ltd. – FDA Inspection, Jul 25, 2019
Record Details
This FDA Inspection record concerns Teva Pharmaceutical Industries Ltd., with an inspection on July 25, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 93e6ba5c-75bf-4f00-841b-b27b299de2e9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1099394
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Teva Pharmaceutical Industries Ltd.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 23, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 22, 2019 | Not classified | Office of Inspections and Investigations | |
| May 25, 2017 | Not classified | Office of Inspections and Investigations | |
| June 15, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 18, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Teva Pharmaceutical Industries Ltd.
- FDA Inspection 1207104 - 2023-05-23
- FDA Inspection 1111726 - 2019-09-22
- FDA Inspection 1016187 - 2017-05-25
- FDA Inspection 935223 - 2015-06-15
- FDA Inspection 849301 - 2013-07-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.